EVQLV

12 employees

Leveraging advances in computation to revolutionize the design and development of therapeutic antibodies for biopharma

Basic info

biotechnology research

Biotechnology

Pharmaceutical

Artificial Intelligence

Life Science

Machine Learning

2019

EVQLV raised undisclosed on August 24, 2023

Investors: Endeavor Miami